# A Study to Evaluate the Safety and Effect of STC3141 Continuous Infusion in Subjects With Severe Corona Virus Disease 2019（COVID-19）Pneumonia

> **NCT04880694** · PHASE2 · COMPLETED · sponsor: **Grand Medical Pty Ltd.** · enrollment: 25 (actual)

## Conditions studied

- Severe COVID-19 Pneumonia

## Interventions

- **DRUG:** STC3141
- **DRUG:** STC3141

## Key facts

- **NCT ID:** NCT04880694
- **Lead sponsor:** Grand Medical Pty Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-20
- **Primary completion:** 2022-01-07
- **Final completion:** 2022-01-07
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2022-04-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04880694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04880694, "A Study to Evaluate the Safety and Effect of STC3141 Continuous Infusion in Subjects With Severe Corona Virus Disease 2019（COVID-19）Pneumonia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04880694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*